TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8241923

Group type: EXPERIMENTAL
Intervention: Cue exposure for at least six sessions over 3 weeks
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control condition (no cue exposure)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Both groups (cue exposure and control)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Cue exposure and control subjects
Number of subjects: 186
Study: 3631029

Group type: EXPERIMENTAL
Intervention: 0.75 mg trimoprostil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.5 mg trimoprostil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 28784042

Group type: EXPERIMENTAL
Intervention: tDCS paired with massed practice training
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 8
Study: 27812703

Group type: EXPERIMENTAL
Intervention: Binocular iPad game (1 hour a day for 16 weeks)
Number of subjects: 385

Group type: COMPARATOR
Intervention: Patching of the fellow eye (2 hours a day for 16 weeks)
Number of subjects: 385
Study: 24728866

Group type: EXPERIMENTAL
Intervention: Group I (LSG begins the division 2 cm from the pylorus)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Group II (LSG begins the division 6 cm from the pylorus)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Group I
Number of subjects: 105

Group type: COMPARATOR
Intervention: Group II
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 105
Study: 23870614

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg administered enterally for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19232762

Group type: EXPERIMENTAL
Intervention: Fibrates
Number of subjects: 11590

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11590
Study: 18208909

Group type: EXPERIMENTAL
Intervention: Citalopram (7 days treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reboxetine (7 days treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16826486

Group type: EXPERIMENTAL
Intervention: BRV-TV vaccine
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: RRV-TV vaccine
Number of subjects: 510

Group type: COMPARATOR
Intervention: Both vaccines
Number of subjects: 510
Study: 12734133

Group type: EXPERIMENTAL
Intervention: Dual-chamber pacing (DDD) with rate drop response
Number of subjects: 100

Group type: COMPARATOR
Intervention: Only sensing without pacing (ODO)
Number of subjects: 100
Study: 11518325

Group type: EXPERIMENTAL
Intervention: Galactooligosaccharide (8 g per day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis Bb-12 (3 x 10^10 cfu per day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Galactooligosaccharide and Bifidobacterium lactis Bb-12
Number of subjects: 0
Study: 9629993

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg tablet (test formulation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg tablet (reference formulation)
Number of subjects: 24
Study: 8165742

Group type: EXPERIMENTAL
Intervention: Chloroquine (25 mg/kg body weight over 3 days)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Sulfadoxine/pyrimethamine (standard doses)
Number of subjects: 152
Study: 3262219

Group type: EXPERIMENTAL
Intervention: Social pressure resistance training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Affective education program
Number of subjects: 0
Study: 31006271

Group type: EXPERIMENTAL
Intervention: Self-reported sleep quality measured by General Sleep Disturbance Scale (GSDS) at 6 weeks postpartum
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Perception of sleep as a 'small' or 'big' problem at 6 weeks postpartum
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Actigraphic sleep measures
Number of subjects: 217
Study: 29525345

Group type: EXPERIMENTAL
Intervention: Iodophor‐impregnated adhesive drapes
Number of subjects: 101

Group type: COMPARATOR
Intervention: No adhesive drapes (Control)
Number of subjects: 101
Study: 28778110

Group type: EXPERIMENTAL
Intervention: SPIKES training program based on video reviews, involving discussions of simulated encounters communicating perinatal loss.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group received no training during the study period but were offered training sessions afterward.
Number of subjects: 44
Study: 25637195

Group type: EXPERIMENTAL
Intervention: Safety decision aid intervention
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual safety planning control website
Number of subjects: 340
Study: 24356654

Group type: EXPERIMENTAL
Intervention: Integrated care pathway for hip fracture patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 20800123

Group type: EXPERIMENTAL
Intervention: Dried plums
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low-fat cookies
Number of subjects: 26
Study: 19140647

Group type: EXPERIMENTAL
Intervention: Specific strategy instructions designed to encourage semantic, integrative encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Condition that encouraged time and attention to encoding but allowed participants to choose their own strategy
Number of subjects: 0
Study: 17153903

Group type: EXPERIMENTAL
Intervention: Home telehealth intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Commercial telehealth systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research projects by University of Minnesota
Number of subjects: 0
Study: 12541152

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography with modification of hemodynamic conditions (group I)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography with modification of hemodynamic conditions (group II)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography with LV volumes method (group I)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography with LV volumes method (group II)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography with Doppler method (group II)
Number of subjects: 55
Study: 10759650

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Untreated (observed) control group
Number of subjects: 228
Study: 8816204

Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms
Number of subjects: 16

Group type: COMPARATOR
Intervention: Salbutamol 400 micrograms
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 1425528

Group type: EXPERIMENTAL
Intervention: Weight reduction programme (6-week course led by public health nurses)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no weight reduction instruction)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 93
Study: 30957394

Group type: EXPERIMENTAL
Intervention: Zero-inflated negative binomial regression model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional normal NLME regression models
Number of subjects: 0
Study: 29790635

Group type: EXPERIMENTAL
Intervention: 1000 mg odourless garlic tablet
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 26818586

Group type: EXPERIMENTAL
Intervention: Active recovery (ACT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Cold-water immersion (CWI)
Number of subjects: 9
Study: 23801526

Group type: EXPERIMENTAL
Intervention: In-home supervised exercise intervention (n=10)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Standardized healthful lifestyle advice
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (n=11)
Number of subjects: 21
Study: 22072492

Group type: EXPERIMENTAL
Intervention: Panobinostat (LBH589), oral administration
Number of subjects: 13
Study: 19880433

Group type: EXPERIMENTAL
Intervention: Medical Qigong (MQ)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 162
Study: 17685673

Group type: EXPERIMENTAL
Intervention: 2 x 15 repetitions maximum (RM)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 3 x 9RM
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 4 x 6RM
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: All training groups (combined)
Number of subjects: 61
Study: 15578202

Group type: EXPERIMENTAL
Intervention: Isometric endurance at different percentages of maximal isometric contraction (MVC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Myoelectrical fatigability (muscle fibre conduction velocity - CV)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Median frequency (MDF) of the surface electromyogram (sEMG) of the biceps brachii
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Torque-velocity curve assessed by maximal isokinetic contractions
Number of subjects: 12
Study: 12137601

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg/day
Number of subjects: 283
Study: 10438996

Group type: EXPERIMENTAL
Intervention: Metformin (1,500 mg for at least a month before FSH stimulation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: FSH stimulation alone (Control)
Number of subjects: 20
Study: 7492894

Group type: EXPERIMENTAL
Intervention: Superbrush (newly designed toothbrush)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Single-headed toothbrush (control)
Number of subjects: 30
Study: 2312778

Group type: EXPERIMENTAL
Intervention: Metoprolol controlled release tablets 100 mg CR/ZOK
Number of subjects: 10

Group type: COMPARATOR
Intervention: Metoprolol conventional tablets 100 mg (CT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Atenolol 50 mg (ATL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7000220

Group type: EXPERIMENTAL
Intervention: Antifibrinolytic therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no antifibrinolytic therapy)
Number of subjects: 100
Study: 30987588

Group type: EXPERIMENTAL
Intervention: Presence of intertrigo
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Increased age
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Care dependency in bathing activities
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Obesity, sex, and skin functional parameters
Number of subjects: 223
Study: 27546524

Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical estriol treatment (0.5 mg estriol ovules for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical estriol treatment
Number of subjects: 50
Study: 25849109

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (PR) with noninvasive positive pressure ventilation
Number of subjects: 55
Study: 23195924

Group type: EXPERIMENTAL
Intervention: Individualized methadone dosages over 100 mg/day with voucher-based cocaine-targeted contingency management (CM)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Fixed dose increase from 70 mg/day to 100 mg/day
Number of subjects: 58
Study: 21950153

Group type: EXPERIMENTAL
Intervention: New pharmaceutical equivalent tablet formulation containing 500 mg of SAQ mesylate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Innovator film coated tablet formulation
Number of subjects: 40
Study: 19703625

Group type: EXPERIMENTAL
Intervention: Experimental group (Imprint 3) - VPS material with heavy-body (HB) and light-body (LB) viscosities
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (Aquasil Ultra) - Standard VPS with medium-body (MB) and light-body (LB) viscosities
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Experimental and Control)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (Aquasil Ultra)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Experimental group (Imprint 3)
Number of subjects: 20
Study: 17107988

Group type: EXPERIMENTAL
Intervention: Beclomethasone 200 microg plus formoterol 12 microg b.i.d. via pMDI
Number of subjects: 219

Group type: COMPARATOR
Intervention: Budesonide 400 microg plus formoterol 12 microg b.i.d. via DPI
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 219
Study: 15041601

Group type: EXPERIMENTAL
Intervention: Haloperidol 1 mg (H1)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Haloperidol 2 mg (H2)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 108
Study: 11734230

Group type: EXPERIMENTAL
Intervention: DiaPep277 (1 mg p277 and 40 mg mannitol in vegetable oil)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (mannitol in vehicle)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: DiaPep277
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 9408726

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8482988

Group type: EXPERIMENTAL
Intervention: 600 mg Statil (Ponalrestat)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 3691679

Group type: EXPERIMENTAL
Intervention: Nebulised adrenaline (1 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nebulised salbutamol (2.5 mg)
Number of subjects: 18
Study: 31125296

Group type: EXPERIMENTAL
Intervention: RHIIT programme
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard programme
Number of subjects: 20
Study: 28394491

Group type: EXPERIMENTAL
Intervention: Therapeutic dose of deferiprone (33 mg/kg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Supratherapeutic dose of deferiprone (50 mg/kg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (positive control)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28211094

Group type: EXPERIMENTAL
Intervention: EGD-colonoscopy
Number of subjects: 209
Study: 25279959

Group type: EXPERIMENTAL
Intervention: Dose intensified hypofractionated intensity-modulated radiotherapy (IMRT) with synchronous cetuximab
Number of subjects: 27
Study: 23295834

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapeutic normothermia
Number of subjects: 0
Study: 21621801

Group type: EXPERIMENTAL
Intervention: Moderate natural fructose diet (50-70 g/d)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Low-fructose diet (<20 g/d)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 131
Study: 18993147

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 10001

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/day
Number of subjects: 10001
Study: 16538688

Group type: EXPERIMENTAL
Intervention: EVS closure device
Number of subjects: 362

Group type: COMPARATOR
Intervention: Manual compression
Number of subjects: 362
Study: 15273178

Group type: EXPERIMENTAL
Intervention: Phlogenzym (rutoside, bromelain, and trypsin)
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Bromelain/Trypsin
Number of subjects: 721

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Phlogenzym
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Trypsin
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Phlogenzym (in subgroup without Caligamed brace)
Number of subjects: 721
Study: 11122832

Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose radioimmunotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted alpha particle therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibody-drug conjugates and immunotoxins
Number of subjects: 0
Study: 9314641

Group type: EXPERIMENTAL
Intervention: Mexiletine 675 mg/day
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 8142985

Group type: EXPERIMENTAL
Intervention: Families with a child conceived by assisted conception (in vitro fertilization and donor insemination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group of families with a naturally conceived child
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group of adoptive families
Number of subjects: 0
Study: 3569230

Group type: EXPERIMENTAL
Intervention: 75 g of glucose (trial G)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 75 g of fructose (trial F)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 150 ml of a sweetened placebo (trial C)
Number of subjects: 6
Study: 30587441

Group type: EXPERIMENTAL
Intervention: Cabozantinib 60 mg orally daily
Number of subjects: 111

Group type: COMPARATOR
Intervention: Weekly paclitaxel 80 mg/m2 given 3 out of 4 weeks
Number of subjects: 111
Study: 27487463

Group type: EXPERIMENTAL
Intervention: Ofloxacin eye drops administered the day before IVI (four times)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Ofloxacin administered one hour before IVI (every 15 minutes)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Combined administration of ofloxacin both one day and one hour before IVI (eight doses)
Number of subjects: 92
Study: 26496309

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 45

Group type: COMPARATOR
Intervention: Open resection
Number of subjects: 45
Study: 23712603

Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 g/kg) in social context (SOC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Alcohol (0.8 g/kg) in isolated context (ISO)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Placebo in social context (SOC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo in isolated context (ISO)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 g/kg) in social context (SOC) with partner receiving alcohol
Number of subjects: 44
Study: 21442198

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 100
Study: 19135998

Group type: EXPERIMENTAL
Intervention: Triple therapy (nitazoxanide 500 mg twice daily, peginterferon alfa‐2a 180 microg once weekly, ribavirin 1000‐1200 mg/day)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Nitazoxanide plus peginterferon alfa‐2a
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard of care (peginterferon alfa‐2a and ribavirin for 48 weeks)
Number of subjects: 96
Study: 17763706

Group type: EXPERIMENTAL
Intervention: Educational videotape intervention
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group (no videotape)
Number of subjects: 325
Study: 15033496

Group type: EXPERIMENTAL
Intervention: Dialectical Behavioral Therapy (DBT) inpatient program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waiting list (treatment as usual)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: DBT inpatient program
Number of subjects: 50
Study: 11534341

Group type: EXPERIMENTAL
Intervention: Isoniazid from a two drugs Fixed Dose Combination (FDC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Separate formulation of isoniazid
Number of subjects: 12
Study: 9537453

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon alfa-n1
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Recombinant interferon alfa-2b
Number of subjects: 1071
Study: 7633476

Group type: EXPERIMENTAL
Intervention: Combination Ho/Nd:YAG laser ablation
Number of subjects: 142

Group type: COMPARATOR
Intervention: Holmium-only technique
Number of subjects: 142
Study: 2577711

Group type: EXPERIMENTAL
Intervention: Diltiazem continuation (Group D)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Diltiazem withdrawal (Group DW)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Reference group (Group R)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Plasma diltiazem concentrations during CPB
Number of subjects: 31
Study: 74457

Group type: EXPERIMENTAL
Intervention: Lithium therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31201188

Group type: EXPERIMENTAL
Intervention: 6 weeks treatment with oral doxycycline
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2 weeks treatment with oral doxycycline
Number of subjects: 120
Study: 27507903

Group type: EXPERIMENTAL
Intervention: FUSE colonoscopy
Number of subjects: 658

Group type: COMPARATOR
Intervention: SFV colonoscopy
Number of subjects: 658
Study: 26401598

Group type: EXPERIMENTAL
Intervention: Reflexology massage (pressure on the right foot for 10 minutes and Shen Men point of the ear for 1 minute)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (routine care only)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo group (pressure on the left foot and left earlobe)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Reflexology group
Number of subjects: 105
Study: 24237937

Group type: EXPERIMENTAL
Intervention: 16 hours of training at the workplace
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 14
Study: 20220046

Group type: EXPERIMENTAL
Intervention: Integrated glucose-insulin model
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Circadian variations in glucose homeostasis
Number of subjects: 59
Study: 19722790

Group type: EXPERIMENTAL
Intervention: FM‐SRP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PM‐SRP
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 17596109

Group type: EXPERIMENTAL
Intervention: HES 130/0.42/6 : 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: HES 130/0.4/9 : 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentastarch (HES 200/0.5/5:1)
Number of subjects: 0
Study: 15238020

Group type: EXPERIMENTAL
Intervention: Verbalization of the perpetrator's description before identification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Forced-choice procedure without verbalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Replication of verbalization effects
Number of subjects: 0
Study: 11327626

Group type: EXPERIMENTAL
Intervention: 24h sodium excretion in postmenopausal women
Number of subjects: 2212

Group type: EXPERIMENTAL
Intervention: 24h sodium excretion in premenopausal women
Number of subjects: 2212

Group type: EXPERIMENTAL
Intervention: Cross-center correlation analyses of 24h sodium excretion
Number of subjects: 2212